Literature DB >> 26310184

Plasma renalase concentration before and after radiofrequency renal denervation in patients with resistant hypertension.

M T Wybraniec1, B Czerwieńska2, M Lelek1, M Adamczak2, A Więcek2, K Mizia-Stec1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26310184     DOI： 10.1038/jhh.2015.94

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  9 in total

1.  12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Authors:  George L Bakris; Raymond R Townsend; John M Flack; Sandeep Brar; Sidney A Cohen; Ralph D'Agostino; David E Kandzari; Barry T Katzen; Martin B Leon; Laura Mauri; Manuela Negoita; William W O'Neill; Suzanne Oparil; Krishna Rocha-Singh; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

2.  Renal denervation causes chronic hypotension in rats: role of beta1-adrenoceptor activity.

Authors:  Frédéric Jacob; Brian G LaBine; Pilar Ariza; Stephen A Katz; John W Osborn
Journal:  Clin Exp Pharmacol Physiol       Date:  2005-04       Impact factor: 2.557

3.  Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells.

Authors:  Shaoxiong Wang; Xi Lu; Jian Yang; Hongyong Wang; CaiYu Chen; Yu Han; Hongmei Ren; Shuo Zheng; Duofen He; Lin Zhou; Laureano D Asico; Wei Eric Wang; Pedro A Jose; Chunyu Zeng
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-05

4.  Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.

Authors:  Jianchao Xu; Guoyong Li; Peili Wang; Heino Velazquez; Xiaoqiang Yao; Yanyan Li; Yanling Wu; Aldo Peixoto; Susan Crowley; Gary V Desir
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

5.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

6.  Catecholamines regulate the activity, secretion, and synthesis of renalase.

Authors:  Guoyong Li; Jianchao Xu; Peili Wang; Heino Velazquez; Yanyan Li; Yanling Wu; Gary V Desir
Journal:  Circulation       Date:  2008-02-25       Impact factor: 29.690

7.  Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.

Authors:  Murray D Esler; Michael Böhm; Horst Sievert; Christian L Rump; Roland E Schmieder; Henry Krum; Felix Mahfoud; Markus P Schlaich
Journal:  Eur Heart J       Date:  2014-06-04       Impact factor: 29.983

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  Impact of renal denervation on renalase expression in adult rats with spontaneous hypertension.

Authors:  Weihong Jiang; Yunzhong Guo; Lihua Tan; Xiaohong Tang; Qiong Yang; Kan Yang
Journal:  Exp Ther Med       Date:  2012-06-20       Impact factor: 2.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.